Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

MIXED(1)
1 unique interventions1 categories

Analytics

Trial Phases

No phase data

Trial Status

Other1

Role Distribution

Principal Investigator1
PI Rate100%

Activity Timeline

Clinical Trials (1)

NCT02035683Not ApplicableUnknown
PET/CT Scan as a Tool to Rationalize the Treatment of of Advanced NSCLC Patients Undergoing First Chemotherapy
Non-small Cell Lung Cancer MetastaticNon-small Cell Lung Cancer Stage IIIB
Principalinvestigator

Research Network

Collaboration Network

31 collaborators·52 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Affiliations

National Cancer Institute, Naples

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Cesare Gridelli, M.D.

S.G. Moscati Hopital, Avellino, Italy, Division of Medical Oncology

Moderately Similar
4 trials

Shared therapeutic areas:

Non-small Cell Lung Cancer MetastaticNon-Small Cell Lung Cancer Stage IIIB

Worked with same sponsors:

National Cancer Institute, Naples
Similarity Score30%

Secondo Lastoria, M.D.

National Cancer Institute, Naples

Related
2 trials

Shared therapeutic areas:

Non-small Cell Lung Cancer MetastaticNon-Small Cell Lung Cancer Stage IIIB

Worked with same sponsors:

National Cancer Institute, Naples
Collaborated on 1 trial
Similarity Score24%

Francesco Perrone, M.D., Ph.D

National Cancer Institute Naples, Italy; Director Clinical Trials Unit

Related
9 trials

Shared therapeutic areas:

Non-small Cell Lung Cancer MetastaticNon-Small Cell Lung Cancer Stage IIIB

Worked with same sponsors:

National Cancer Institute, Naples
Collaborated on 1 trial
Similarity Score24%

Ciro Gallo, M.D., Ph.D

Second University of Naples, Italy; Chair of Medical Statistics

Related
8 trials

Shared therapeutic areas:

Non-small Cell Lung Cancer MetastaticNon-Small Cell Lung Cancer Stage IIIB

Worked with same sponsors:

National Cancer Institute, Naples
Collaborated on 1 trial
Similarity Score24%

Massimo Di Maio, M.D.

National Cancer Institute, Naples

Related
5 trials

Shared therapeutic areas:

Non-small Cell Lung Cancer MetastaticNon-Small Cell Lung Cancer Stage IIIB

Worked with same sponsors:

National Cancer Institute, Naples
Collaborated on 1 trial
Similarity Score24%

Alessandro Morabito, M.D.

National Cancer Institute, Naples

Related
1 trials

Shared therapeutic areas:

Non-small Cell Lung Cancer MetastaticNon-Small Cell Lung Cancer Stage IIIB

Worked with same sponsors:

National Cancer Institute, Naples
Collaborated on 1 trial
Similarity Score24%

Anna Paola Fraccon, MD

Casa di Cura Dott. Pederzoli - Peschiera del Garda

Related
1 trials

Shared therapeutic areas:

Non-Small Cell Lung Cancer Stage IIIB
Similarity Score15%

Hector Soto Parra, MD

A. Ospedaliero-Universitaria Policlinico Vittorio Emanuele - Catania

Related
1 trials

Shared therapeutic areas:

Non-Small Cell Lung Cancer Stage IIIB
Similarity Score15%

Alessandro Del Conte, MD

A.O. Santa Maria Degli Angeli - Pordenone

Related
1 trials

Shared therapeutic areas:

Non-Small Cell Lung Cancer Stage IIIB
Similarity Score15%

Luigi Cavanna, MD

AUSL Piacenza - Ospedale Guglielmo da Saliceto

Related
1 trials

Shared therapeutic areas:

Non-Small Cell Lung Cancer Stage IIIB
Similarity Score15%

Publications (0)

No publications found for this investigator.

Clinical Trials (1)

Showing 1 of 1 trials

NCT02035683Not ApplicablePrincipalInvestigator

PET/CT Scan as a Tool to Rationalize the Treatment of of Advanced NSCLC Patients Undergoing First Chemotherapy

Non-small Cell Lung Cancer MetastaticNon-small Cell Lung Cancer Stage IIIB
Unknown

All 1 trials loaded